204 related articles for article (PubMed ID: 25112228)
1. Treatment of hyperprolactinemia in post-menopausal women: pros.
Iacovazzo D; De Marinis L
Endocrine; 2015 Feb; 48(1):76-8. PubMed ID: 25112228
[TBL] [Abstract][Full Text] [Related]
2. The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons.
Faje AT; Klibanski A
Endocrine; 2015 Feb; 48(1):79-82. PubMed ID: 24888765
[No Abstract] [Full Text] [Related]
3. Hyperprolactinemia after menopause: Diagnosis and management.
Auriemma RS; Pirchio R; Pivonello R; Colao A
Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
[TBL] [Abstract][Full Text] [Related]
4. Prolactinomas.
Glezer A; Bronstein MD
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management.
Pekić S; Medic Stojanoska M; Popovic V
Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
7. [Hyperprolactinemia in the postmenopause: versions and contraversions].
Leshchenko OY
Ter Arkh; 2021 Oct; 93(10):1234-1239. PubMed ID: 36286827
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinaemia.
Prabhakar VK; Davis JR
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
[TBL] [Abstract][Full Text] [Related]
9. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
10. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
11. [Prolactinoma].
Glezer A; Bronstein MD
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
[TBL] [Abstract][Full Text] [Related]
12. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
13. [Hyperprolactinemia and prolactinomas].
Croughs RJ; van 't Verlaat JW
Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2210-3. PubMed ID: 1956454
[No Abstract] [Full Text] [Related]
14. Pituitary production of prolactin and prolactin-suppressing drugs.
Tansey MJ; Schlechte JA
Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
[TBL] [Abstract][Full Text] [Related]
15. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
Scoccia B; Schneider AB; Marut EL; Scommegna A
J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
Chanson P; Maiter D
Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101290. PubMed ID: 31326373
[TBL] [Abstract][Full Text] [Related]
17. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
18. Major depressive disorder induced by prolactinoma--a case report.
Liao WT; Bai YM
Gen Hosp Psychiatry; 2014; 36(1):125.e1-2. PubMed ID: 24182617
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment of hyperprolactinemia.
Chanson P; Borson-Chazot F; Chabre O; Estour B
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):113-7. PubMed ID: 17532288
[TBL] [Abstract][Full Text] [Related]
20. Speed of response to dopaminergic agents in prolactinomas.
Hage C; Salvatori R
Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
